Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
13 pending office actions • 12 clients • 12 examiners • 11 art units • 0 of 13 (0%) have an AI response strategy ready
Culhane Meadows PLLC operates as a patent law firm with a portfolio of 654 career applications. The firm primarily serves the Biotechnology & Pharmaceuticals technology area. The firm has secured a resolved allowance rate pct of 90.22. This metric indicates the firm's results in navigating the USPTO examination process for its clients.
The firm averages an avg office actions per allowance of 3.77. This figure describes a prosecution style where several rounds of negotiation with examiners occur before reaching a final grant. Practitioners can view the 15 pending office actions as a snapshot of the firm's current active workload. The combination of a 90.22 resolved allowance rate pct and 3.77 avg office actions per allowance reflects a strategy that results in patent issuance. For stakeholders, these data points demonstrate the track record across 654 career applications. The firm's work in Biotechnology & Pharmaceuticals is reflected in these prosecution metrics.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (8%) |
| §103 only | 2 (15%) |
| Double-patenting only | 1 (8%) |
| Double-patenting + other | 2 (15%) |
| Multi-statute (no §101) | 7 (54%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YOO, SUN JAE | 2 | 71.1% | +0.3% |
| ALAM, HOSAIN T | 1 | 65.5% | +16.3% |
| SONG, JIANFENG | 1 | 56.3% | +33.2% |
| GZYBOWSKI, MICHAEL STANLEY | 1 | 68.3% | +52.0% |
| REDDY, KARUNA P | 1 | 42.5% | +10.4% |
| PALENIK, JEFFREY T | 1 | 53.6% | +27.2% |
| PATERSON, BRIGITTE A | 1 | 76.5% | +22.6% |
| PURDY, KYLE A | 1 | 41.0% | +35.9% |
| SOROUSH, LAYLA | 1 | 40.5% | +43.4% |
| WESTERBERG, NISSA M | 1 | 23.4% | +37.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17554511 | INTEGRATED ELECTRONICS ON THE ALUMINUM NITRIDE PLATFORM | SHEKER, RHYS PONIENTE | 22d |
| 18920276 | EXECUTING HIERARCHICAL DATA SPACE OPERATIONS | ALAM, HOSAIN T | 62d |
| 18502783 | PROTONATED pH RESPONSIVE POLYMER ENCAPSULATION OF BISPECIFIC ANTIBODIES AND CYTOKINES | SONG, JIANFENG | — |
| 18551012 | VIRAL FILTER AND METHOD OF VIRAL FILTRATION | GZYBOWSKI, MICHAEL STANLEY | — |
| 18280649 | CROSSLINKED POLY (ALLYLAMINE) POLYMER PHARMACEUTICAL COMPOSITIONS | REDDY, KARUNA P | — |
| 18277519 | Integrated Quantum Computing with Epitaxial Materials | PATERSON, BRIGITTE A | — |
| 18008271 | COMPOSITIONS | PURDY, KYLE A | — |
| 17756190 | PH RESPONSIVE COMPOSITIONS, FORMULATIONS, AND METHODS OF IMAGING A TUMOR | WESTERBERG, NISSA M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17784243 | LIQUID PHARMACEUTICAL COMPOSITION COMPRISING CYTISINE | SOROUSH, LAYLA | 9d |
| 18920276 | EXECUTING HIERARCHICAL DATA SPACE OPERATIONS | ALAM, HOSAIN T | 62d |
| 18502783 | PROTONATED pH RESPONSIVE POLYMER ENCAPSULATION OF BISPECIFIC ANTIBODIES AND CYTOKINES | SONG, JIANFENG | — |
| 18551012 | VIRAL FILTER AND METHOD OF VIRAL FILTRATION | GZYBOWSKI, MICHAEL STANLEY | — |
| 18280649 | CROSSLINKED POLY (ALLYLAMINE) POLYMER PHARMACEUTICAL COMPOSITIONS | REDDY, KARUNA P | — |
| 18238665 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | PALENIK, JEFFREY T | — |
| 18277519 | Integrated Quantum Computing with Epitaxial Materials | PATERSON, BRIGITTE A | — |
| 18008271 | COMPOSITIONS | PURDY, KYLE A | — |
| Art Unit | Apps |
|---|---|
| 1621 | 2 |
| 2132 | 1 |
| 1675 | 1 |
| 1798 | 1 |
| 1764 | 1 |
| 1615 | 1 |
| 1611 | 1 |
| 1622 | 1 |
| 1618 | 1 |
| 3761 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18920276 | EXECUTING HIERARCHICAL DATA SPACE OPERATIONS | Craxel, Inc. | ALAM, HOSAIN T | 2132 | §101§102§103 | Final Rejection | 62d | Pending | Oct 18, 2024 |
| 18797649 | COMPOSITIONS, KITS, AND METHODS TO INDUCE ACQUIRED CYTORESISTANCE USING STRESS PROTEIN INDUCERS | Fred Hutchinson Cancer Research Center | YOO, SUN JAE | 1621 | DP | Non-Final OA | — | Pending | Aug 08, 2024 |
| 18428728 | Novel Stannic Protoporfin Compositions, Methods of Making, and Uses Thereof | Renibus Therapeutics, Inc. | YOO, SUN JAE | 1621 | §103 | Non-Final OA | — | Pending | Jan 31, 2024 |
| 18502783 | PROTONATED pH RESPONSIVE POLYMER ENCAPSULATION OF BISPECIFIC ANTIBODIES AND CYTOKINES | Onconano Medicine, Inc. | SONG, JIANFENG | 1675 | §103§112Other | Non-Final OA | — | Pending | Nov 06, 2023 |
| 18551012 | VIRAL FILTER AND METHOD OF VIRAL FILTRATION | Global Life Sciences Solutions Operations UK Ltd. | GZYBOWSKI, MICHAEL STANLEY | 1798 | §103§112 | Final Rejection | — | Pending | Sep 18, 2023 |
| 18280649 | CROSSLINKED POLY (ALLYLAMINE) POLYMER PHARMACEUTICAL COMPOSITIONS | Renosis, Inc. | REDDY, KARUNA P | 1764 | §103§112 | Final Rejection | — | Pending | Sep 06, 2023 |
| 18238665 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | Renosis, Inc. | PALENIK, JEFFREY T | 1615 | §103DPOther | Final Rejection | — | Pending | Aug 28, 2023 |
| 18277519 | Integrated Quantum Computing with Epitaxial Materials | Cornell University | PATERSON, BRIGITTE A | §102§112 | Non-Final OA | — | Pending | Aug 16, 2023 | |
| 18008271 | COMPOSITIONS | Jvs Products Limited | PURDY, KYLE A | 1611 | §103§112 | Non-Final OA | — | Pending | Dec 05, 2022 |
| 17784243 | LIQUID PHARMACEUTICAL COMPOSITION COMPRISING CYTISINE | Adamed Pharma S.A. | SOROUSH, LAYLA | 1622 | §103 | Non-Final OA | 9d | Pending | Aug 02, 2022 |
| 17756190 | PH RESPONSIVE COMPOSITIONS, FORMULATIONS, AND METHODS OF IMAGING A TUMOR | Onconano Medicine, Inc. | WESTERBERG, NISSA M | 1618 | §103DPOther | Final Rejection | — | Pending | May 18, 2022 |
| 17632499 | APPARATUS FOR HEATING AND FOAMING A LIQUID, IN PARTICULAR A BEVERAGE | Eversys Holding SA | KHLOK, BONITA | 3761 | §103§112 | Non-Final OA | — | Pending | Feb 02, 2022 |
| 17554511 | INTEGRATED ELECTRONICS ON THE ALUMINUM NITRIDE PLATFORM | Cornell University | SHEKER, RHYS PONIENTE | 2813 | §103§112 | Final Rejection | 22d | Pending | Dec 17, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial